ASCORBIC ACID

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C6H8O6
Molecular Weight	176.1241
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO

InChI

InChIKey=CIWBSHSKHKDKBQ-JLAZNSOCSA-N

InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C6H8O6
Molecular Weight	176.1241
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: http://www.rxlist.com/ascorbic-acid-drug.htm | https://www.ncbi.nlm.nih.gov/pubmed/12569111 | https://www.ncbi.nlm.nih.gov/pubmed/25307916 | https://www.ncbi.nlm.nih.gov/pubmed/15254232

Ascorbic acid (vitamin C) is a water-soluble vitamin. It occurs as a white or slightly yellow crystal or powder with a slight acidic taste. Ascorbic acid is an electron donor, and this property accounts for all its known functions. As an electron donor, ascorbic acid is a potent water-soluble antioxidant in humans. Ascorbic acid acts as an antioxidant under physiologic conditions exhibiting a cross over role as a pro-oxidant in pathological conditions. Oxidized ascorbic acid (dehydroascorbic acid (DHA) directly inhibits IkappaBalpha kinase beta (IKKbeta) and IKKalpha enzymatic activity in vitro, whereas ascorbic acid did not have this effect. These findings define a function for vitamin C in signal transduction other than as an antioxidant and mechanistically illuminate how vitamin C down-modulates NF-kappaB signaling. Vitamin C is recommended for the prevention and treatment of scurvy. Its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid (vitamin c) is uncertain. Symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. Febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increase the need for ascorbic acid (vitamin c). Hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Oxidative Stress 160 Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12569111 \| https://www.ncbi.nlm.nih.gov/pubmed/25307916	Inhibitor 8297
Inhibitor of nuclear factor kappa B kinase beta subunit 16 Target ID: CHEMBL1991 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15254232	Inhibitor 8297
Inhibitor of nuclear factor kappa B kinase alpha subunit 9 Target ID: CHEMBL3476 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15254232	Inhibitor 8297

Conditions

Condition	Modality	Targets	Highest Phase	Product
Scurvy 5 Sources: http://www.rxlist.com/ascorbic-acid-drug.htm	Preventing		Approved 8429	Vitamin C Approved Use Vitamin C is recommended for the prevention and treatment of scurvy. Its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid (vitamin c) is uncertain. Symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. Febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increase the need for ascorbic acid (vitamin c) . Hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake
Vitamin C deficiency 6 Sources: http://www.rxlist.com/ascorbic-acid-drug.htm	Preventing		Approved 8429	Vitamin C Approved Use Vitamin C is recommended for the prevention and treatment of scurvy. Its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid (vitamin c) is uncertain. Symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. Febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increase the need for ascorbic acid (vitamin c) . Hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake

C_max

Value	Dose	Co-administered	Analyte	Population
33 mM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23670640/	50 g/m² 1 times / day multiple, intravenous dose: 50 g/m² route of administration: Intravenous experiment type: MULTIPLE co-administered:		ASCORBIC ACID plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

AUC

Value	Dose	Co-administered	Analyte	Population
124 mM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23670640/	50 g/m² 1 times / day multiple, intravenous dose: 50 g/m² route of administration: Intravenous experiment type: MULTIPLE co-administered:		ASCORBIC ACID plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
1.8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/23670640/	50 g/m² 1 times / day multiple, intravenous dose: 50 g/m² route of administration: Intravenous experiment type: MULTIPLE co-administered:		ASCORBIC ACID plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

Doses

Dose	Population	Adverse events
15 mg/kg 2 times / day multiple, oral Studied dose Dose: 15 mg/kg, 2 times / day Route: oral Route: multiple Dose: 15 mg/kg, 2 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/19427269 Page: p.541	unhealthy, ADULT n = 42 Health Status: unhealthy Condition: Charcot-Marie-Tooth disease Age Group: ADULT Sex: M+F Population Size: 42 Sources: https://pubmed.ncbi.nlm.nih.gov/19427269 Page: p.541	Sources: https://pubmed.ncbi.nlm.nih.gov/19427269 Page: p.541
1.5 g/kg 3 times / week multiple, intravenous Dose: 1.5 g/kg, 3 times / week Route: intravenous Route: multiple Dose: 1.5 g/kg, 3 times / week Sources: https://pubmed.ncbi.nlm.nih.gov/28847527 Page: p.414	unhealthy, ADULT n = 15 Health Status: unhealthy Condition: Non-small cell lung cancer Age Group: ADULT Sex: M+F Food Status: FASTED Population Size: 15 Sources: https://pubmed.ncbi.nlm.nih.gov/28847527 Page: p.414	Other AEs: Diarrhea... Other AEs: Diarrhea (grade 3, 6.7%) Sources: https://pubmed.ncbi.nlm.nih.gov/28847527 Page: p.414
110 g/m2 1 times / day multiple, intravenous Dose: 110 g/m2, 1 times / day Route: intravenous Route: multiple Dose: 110 g/m2, 1 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/23670640 Page: p.143	unhealthy, ADULT n = 3 Health Status: unhealthy Condition: cancer Age Group: ADULT Sex: M+F Food Status: UNKNOWN Population Size: 3 Sources: https://pubmed.ncbi.nlm.nih.gov/23670640 Page: p.143	Sources: https://pubmed.ncbi.nlm.nih.gov/23670640 Page: p.143

AEs

AE	Significance	Dose	Population
Diarrhea	grade 3, 6.7%	1.5 g/kg 3 times / week multiple, intravenous Dose: 1.5 g/kg, 3 times / week Route: intravenous Route: multiple Dose: 1.5 g/kg, 3 times / week Sources: https://pubmed.ncbi.nlm.nih.gov/28847527 Page: p.414	unhealthy, ADULT n = 15 Health Status: unhealthy Condition: Non-small cell lung cancer Age Group: ADULT Sex: M+F Food Status: FASTED Population Size: 15 Sources: https://pubmed.ncbi.nlm.nih.gov/28847527 Page: p.414

Overview

CYP3A4	CYP2C9	CYP2D6	hERG
inducer 781

OverviewOther

Other Inhibitor	Other Substrate	Other Inducer

Drug as perpetrator

Target	Modality	Activity	Metabolite	Clinical evidence
CYP3A4 1925	inducer 1573 Sources: https://pubmed.ncbi.nlm.nih.gov/16305291/ Page: 4.0	moderate
CYP1A2 1692	supressor 155 Sources: https://pubmed.ncbi.nlm.nih.gov/8269614/ Page: 4.0	yes

Sourcing

Vendor/Aggregator	ID	URL
3B Scientific (Wuhan) Corp	3B1-00242	http://www.3bsc.com/index/pro_info.php?id=20454
AA Blocks	AA00I8UB	http://www.aablocks.com/goods/Goods/detail?id=AA00I8UB
AHH Chemical co.,ltd	MR-1086517	http://www.ahhchemical.com/product/MR-1086517.html
AHH Chemical co.,ltd	NP-1173	http://www.ahhchemical.com/product/NP-1173.html
AK Scientific, Inc. (AKSCI)	67510	http://www.aksci.com/item_detail.php?cat=67510
Aaron Chemicals	AR00I9M3	http://www.aaronchem.com/50-81-7
AbMole Bioscience	M3121	http://www.abmole.com/products/vitamin-c.html
Acadechem	ACDS-067182	http://www.acadechemical.com/product/141881
Achemo Scientific Limited	AC-74207	http://www.achemo.com/search/?Keyword= 50-81-7
Achemtek	0104-010562	http://www.achemtek.com/50-81-7
Achemtek	0104-017144	http://www.achemtek.com/62624-30-0
Acros Organics	AC105021000	https://www.fishersci.com/shop/products/l-ascorbic-acid-99-acros-organics-1/AC105021000
Acros Organics	AC105025000	https://www.fishersci.com/shop/products/l-ascorbic-acid-99-acros-organics-1/AC105025000
Acros Organics	AC105020025	https://www.fishersci.com/shop/products/l-ascorbic-acid-99-acros-organics/AC105020025
Acros Organics	AC401471000	https://www.fishersci.com/shop/products/l-ascorbic-acid-reagent-acs-99-acros-organics-1/AC401471000
Acros Organics	AC401470025	https://www.fishersci.com/shop/products/l-ascorbic-acid-reagent-acs-99-acros-organics/AC401470025
Alfa Aesar	36237	https://www.alfa.com/en/catalog/036237/
Alfa Aesar	A15613	https://www.alfa.com/en/catalog/A15613/
Alfa Aesar	11188	https://www.alfa.com/en/catalog/B22607/
Alfa Chemistry	AP50817-A	https://reagents.alfa-chemistry.com/product/ascorbic-acid-cas-50-81-7-12193.html
Alfa Chemistry	AP50817-B	https://reagents.alfa-chemistry.com/product/l-ascorbic-acid-cas-50-81-7-12194.html
Alfa Chemistry	ACM50817	https://www.alfa-chemistry.com/l-ascorbic-acid-cas-50-81-7-item-1407.htm
Angene	AGN-PC-0S92Y2	http://www.angenechemical.com/productshow/AGN-PC-0S92Y2.html
Anward	ANW-73969	http://www.anward.com/pro_result/60420
ApexBio Technology	A8158	http://www.apexbt.com/ascorbic-acid-1654.html
ApexBio Technology	B2064	http://www.apexbt.com/vitamin-c.html
Avantor Inc	101178-431	https://us.vwr.com/store/catalog/product.jsp?catalog_number=101178-431
Avantor Inc	BT218855-100G	https://us.vwr.com/store/product/16639814/l-ascorbic-acid-99
Avantor Inc	700009-366	https://us.vwr.com/store/product/21572544/l-ascorbic-acid-99-0-crystalline-powder-usp
Avantor Inc	BJ05878-100G	https://us.vwr.com/store/product/26203401/l-ascorbic-acid-99-9998-metals-basis-traceselecttm-flukatm
Avantor Inc	200003-712	https://us.vwr.com/store/product/7520532/l-ascorbic-acid
BLD Pharm	BD21086	http://www.bldpharm.com/products/50-81-7.html
BioChemPartner	BCP27915	http://www.biochempartner.com/50-81-7-BCP27915
BroadPharm	BP-12831	http://www.broadpharm.com/web/product.php?catalog=BP-12831
CSNpharm	CSN12698	https://www.csnpharm.com/products/l-ascorbic-acid.html
Capot Chemical	18445	http://www.capotchem.com/en/18445.htm
Capot Chemical	PubChem18445	http://www.capotchem.com/en/18445.htm
Chem Scene	CS-2006	http://www.chemscene.com/50-81-7.html
ChemFaces	CFN90048	http://www.chemfaces.com/natural/Ascorbic-acid-CFN90048.html
ChemMol	83602591	http://www.chemmol.com/chemmol/83602591.html
ChemMol	99067320	http://www.chemmol.com/chemmol/99067320.html
ChemMol	99097734	http://www.chemmol.com/chemmol/99097734.html
Chemspace	CSSB00015747123	https://chem-space.com/CSSB00015747123
China MainChem Co., Ltd	MS50-81-7	https://www.mainchem.com/product/l-ascorbic-acid/
Clearsynth	CS-O-00843	https://www.clearsynth.com/en/CSO00843.html
DC Chemicals	DCW-017	http://www.dcchemicals.com//product_show-Vitamin_C.html
Fisher Chemical	A62212	https://www.fishersci.com/shop/products/ascorbic-acid-powder-usp-fcc-fisher-chemical-3/p-61096
Fisher Chemical	A62500	https://www.fishersci.com/shop/products/ascorbic-acid-powder-usp-fcc-fisher-chemical-3/p-61096
Fisher Chemical	A61100	https://www.fishersci.com/shop/products/l-ascorbic-acid-crystalline-certified-acs-fisher-chemical-2/p-61088
Fisher Chemical	A6125	https://www.fishersci.com/shop/products/l-ascorbic-acid-crystalline-certified-acs-fisher-chemical-2/p-61088
Glentham Life Sciences	GV5017	http://www.glentham.com/products/product/GV5017/
LGC Standards	DRE-A10303000AL-1000	https://www.lgcstandards.com/US/en/p/DRE-A10303000AL-1000
LGC Standards	DRE-C10303000	https://www.lgcstandards.com/US/en/p/DRE-C10303000
LGC Standards	LGCFOR0166.00	https://www.lgcstandards.com/US/en/p/LGCFOR0166.00
LGC Standards	MM0166.00	https://www.lgcstandards.com/US/en/p/MM0166.00
Lab Network	LN00193462	https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN00193462
Matrix Scientific	97771	https://www.matrixscientific.com/097771.html
MedChem Express	HY-B0166	https://www.medchemexpress.com/L-Ascorbic-acid.html
Oakwood	103811	http://www.oakwoodchemical.com/ProductsList.aspx?CategoryID=-2&txtSearch=194719&ExtHyperLink=1
Oakwood	93967	http://www.oakwoodchemical.com/ProductsList.aspx?CategoryID=-2&txtSearch=79141&ExtHyperLink=1
Parchem	7675	http://www.parchem.com/chemical-supplier-distributor/Ascorbic-Acid-009576.aspx
R&D Chemicals	708	http://www.rdchemicals.com/chemicals.php?mode=details&mol_id=7530
Renno Tech	RP23765	http://www.rennotech.com/product_show.asp?id=29422
Sigma-Aldrich	01-6730_SAJ	https://www.sigmaaldrich.com/catalog/product/saj/016730?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	01-6739_SAJ	https://www.sigmaaldrich.com/catalog/product/saj/016739?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	255564_SIAL	https://www.sigmaaldrich.com/catalog/product/sial/255564?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	33034_SIAL	https://www.sigmaaldrich.com/catalog/product/sial/33034?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sigma-Aldrich	1043003_USP	https://www.sigmaaldrich.com/catalog/product/usp/1043003?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Sinfoo Biotech	S051525	http://www.sinfoobiotech.com/product/1054923
Smolecule	S519480	http://www.smolecule.com/products/s519480
TCI (Tokyo Chemical Industry)	A0537	http://www.tcichemicals.com/eshop/en/us/commodity/A0537/index.html
THE BioTek	bt-260185	https://www.thebiotek.com/product/inhibitors/bt-260185
Tocris	4055	https://www.tocris.com/products/l-ascorbic-acid_4055
VladaChem	VL140373	https://www.vladachem.com/product.php?products=50-81-7
VladaChem	VL161489	https://www.vladachem.com/product.php?products=50-81-7
VladaChem	VL161492	https://www.vladachem.com/product.php?products=50-81-7
abcr GmbH	AB113794	http://www.abcr.com/shop/en/AB113794
abcr GmbH	AB207947	http://www.abcr.com/shop/en/AB207947
eNovation Chemicals	D376563	http://www.enovationchem.com/productDetails.asp?productID=D376563
eNovation Chemicals	D673405	https://www.enovationchem.com/ProductDetails.asp?ProductID=D673405
iChemical	EBD897829	http://www.ichemical.com/products/50-81-7.html?utm_source=PubChem&utm_medium=website&utm_campaign=product%20catalogs

PubMed

Title	Date	PubMed
Vanadium and ascorbate effects on 3-hydroxy-3-methylglutaryl coenzyme A reductase, cholesterol and tissue minerals in guinea pigs fed low-chromium diets.	1991-1992	1669016
Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats.	2000 Jul	10904027
Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia.	2000 Oct	10942521
Mutagenicity of food-derived carcinogens and the effect of antioxidant vitamins.	2002	12467141
Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide.	2002 Nov 22	12239215
Search of antimicrobial activity of selected non-antibiotic drugs.	2002 Nov-Dec	12669766
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).	2002 Oct 25	12192006
Up-regulation and polarized expression of the sodium-ascorbic acid transporter SVCT1 in post-confluent differentiated CaCo-2 cells.	2003 Mar 14	12381735
Toluene diisocyanate exposure induces laryngo-tracheal eosinophilia, which can be ameliorated by supplementation with antioxidant vitamins in guinea pigs.	2003 Oct	14606601
Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.	2003 Oct 15	12871208
Incorporation of an oxygen from water into troglitazone quinone by cytochrome P450 and myeloperoxidase.	2004 Apr	15039298
Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.	2004 Apr	15034573
Nelfinavir induces necrosis of 3T3F44-2A adipocytes by oxidative stress.	2004 Dec 15	15577407
Vitamin C and vitamin E protect the rat testes from cadmium-induced reactive oxygen species.	2004 Feb 29	15055539
Micronutrient deficiencies as predisposing factors for hypertension in lacto-vegetarian Indian adults.	2004 Jun	15190049
Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells.	2004 Jun	15130278
Involvement of glycosylphosphatidylinositol-linked ceruloplasmin in the copper/zinc-nitric oxide-dependent degradation of glypican-1 heparan sulfate in rat C6 glioma cells.	2004 Mar 26	14707133
Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel.	2004 Mar 9	14993613
The amyloid precursor protein (APP) of Alzheimer disease and its paralog, APLP2, modulate the Cu/Zn-Nitric Oxide-catalyzed degradation of glypican-1 heparan sulfate in vivo.	2005 Apr 8	15677459
[Effect of compound salvia injection on nitrate ester tolerance].	2005 Jan	15719745
Studies on the protective role of vitamin C and E against polychlorinated biphenyl (Aroclor 1254)--induced oxidative damage in Leydig cells.	2005 Nov	16298753
Morphology and DNA degeneration during autoschizic cell death in bladder carcinoma T24 cells induced by ascorbate and menadione treatment.	2006 Jan	16345077
Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase.	2006 Mar 17	16377630

Patents

Sample Use Guides

In Vivo Use Guide

Ascorbic acid (vitamin c) is usually administered orally. When oral administration is not feasible or when malabsorption is suspected, the drug may be administered IM, IV, or subcutaneously. When given parenterally, utilization of the vitamin reportedly is best after IM administration and that is the preferred parenteral route. For intravenous injection, dilution into a large volume parenteral such as Normal Saline, Water for Injection, or Glucose is recommended to minimize the adverse reactions associated with intravenous injection. The average protective dose of vitamin C for adults is 70 to 150 mg daily. In the presence of scurvy, doses of 300 mg to 1 g daily are recommended. However, as much as 6 g has been administered parenterally to normal adults without evidence of toxicity. To enhance wound healing, doses of 300 to 500 mg daily for a week or ten days both preoperatively and postoperatively are generally considered adequate, although considerably larger amounts have been recommended. In the treatment of burns, doses are governed by the extent of tissue injury. For severe burns, daily doses of 1 to 2 g are recommended. In other conditions in which the need for vitamin C is increased, three to five times the daily optimum allowances appear to be adequate. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit.

Route of Administration: Other

In Vitro Use Guide

cell-derived decellularized extracellular matrix (dECM) with 250 µM of L-ascorbic acid phosphate (AA) treatment for 10 d had better rejuvenation in chondrogenic capacity if the deposited cells were from passage 2 rather than passage 5, despite no significant difference in matrix stiffness. In the dose regimen study, we found that dECMs deposited by varied concentrations of AA yielded expanded cells with higher proliferation capacity despite lower expression levels of stem cell related surface markers. Compared to cells expanded on tissue culture polystyrene, those on dECM exhibited greater chondrogenic potential, particularly for the dECMs with 50 µM and 250 µM of AA treatment. With the supplementation of ethyl-3,4-dihydroxybenzoate (EDHB), an inhibitor targeting procollagen synthesis, the dECM with 50 µM of AA treatment exhibited a dramatic decrease in the rejuvenation effect of expanded cell chondrogenic potential at both mRNA and protein levels despite no significant difference in matrix stiffness.

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:21:10 GMT 2023` Edited by `admin` on `Fri Dec 15 15:21:10 GMT 2023`
Record UNII	PQ6CK8PD0R
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ASCORBIC ACID

Official Name

English

Ascorbic acid [WHO-DD]

Common Name

English

ASCORBICUM ACIDUM

Common Name

English

ASCORBATE

Common Name

English

E-300

Code

English

3-KETO-L-GULOFURANOLACTONE

Common Name

English

ASCORBIC ACID [WHO-IP]

Common Name

English

ASCORBICAP

Brand Name

English

ASCORBIC ACID [JAN]

Common Name

English

ASCOLTIN

Brand Name

English

L-ASCORBIC ACID

Common Name

English

VITAMIN C [VANDF]

Common Name

English

ASCORBIC ACID [MI]

Common Name

English

ASCORBIC ACID, L-

Common Name

English

ASCORBIC ACID [HSDB]

Common Name

English

NSC-218455

Code

English

ACIDUM ASCORBICUM [WHO-IP LATIN]

Common Name

English

INS-300

Code

English

ASCORBIC ACID [FCC]

Common Name

English

ASCORBIC ACID [ORANGE BOOK]

Common Name

English

INS NO.300

Code

English

ASCORBIC ACID [INCI]

Common Name

English

ASCORBIC ACID [FHFI]

Common Name

English

ASCORBIC ACID [II]

Common Name

English

ASCORBIC ACID [USP MONOGRAPH]

Common Name

English

ASCORBIC ACID [MART.]

Common Name

English

ASCORBIC ACID [USP-RS]

Common Name

English

L-ASCORBATE

Common Name

English

2,3-DEHYDRO-L-THREO-HEXONO-1,4-LACTONE

Common Name

English

VITAMIN C

Systematic Name

English

ASCORBIC ACID [VANDF]

Common Name

English

FEMA NO. 2109

Code

English

NSC-33832

Code

English

ASCORBIC ACID [EP MONOGRAPH]

Common Name

English

(5R)-5-((1S)-1,2-DIHYDROXYETHYL)-3,4-DIHYDROXYFURAN-2(5H)-ONE

Systematic Name

English

ASCOR

Brand Name

English

VITAMIN C (AS ASCORBIC ACID)

Common Name

English

ascorbic acid [INN]

Common Name

English

Classification Tree Code System Code

LOINC

54351-2